Published on in Vol 6, No 10 (2022): October
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/41415, first published
.
![Impact of the COVID-19 Pandemic on the Implementation of Mobile Health to Improve the Uptake of Hydroxyurea in Patients With Sickle Cell Disease: Mixed Methods Study Impact of the COVID-19 Pandemic on the Implementation of Mobile Health to Improve the Uptake of Hydroxyurea in Patients With Sickle Cell Disease: Mixed Methods Study](https://asset.jmir.pub/assets/e1ae3c3a11a41890e57ccb4014d058c5.png 480w,https://asset.jmir.pub/assets/e1ae3c3a11a41890e57ccb4014d058c5.png 960w,https://asset.jmir.pub/assets/e1ae3c3a11a41890e57ccb4014d058c5.png 1920w,https://asset.jmir.pub/assets/e1ae3c3a11a41890e57ccb4014d058c5.png 2500w)
Journals
- Hankins J, Potter M, Fernandez M, Melvin C, DiMartino L, Jacobs S, Bosworth H, King A, Simon J, Glassberg J, Kutlar A, Gordeuk V, Shah N, Baumann A, Klesges L. Evaluating the implementation of a multi-level mHealth study to improve hydroxyurea utilization in sickle cell disease. Frontiers in Health Services 2023;2 View
- Rai P, Okhomina V, Kang G, Martinez H, Hankins J, Joshi V. Longitudinal effect of disease‐modifying therapy on left ventricular diastolic function in children with sickle cell anemia. American Journal of Hematology 2023;98(6):838 View
- Hankins J, Brambilla D, Potter M, Kutlar A, Gibson R, King A, Baumann A, Melvin C, Gordeuk V, Hsu L, Nwosu C, Porter J, Alberts N, Badawy S, Simon J, Glassberg J, Lottenberg R, DiMartino L, Jacobs S, Fernandez M, Bosworth H, Klesges L, Shah N. A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease. Blood Advances 2023;7(23):7190 View
- Nwosu C, Khan H, Masese R, Nocek J, Gollan S, Varughese T, Bourne S, Clesca C, Jacobs S, Baumann A, Klesges L, Shah N, Hankins J, Smeltzer M. Recruitment Strategies in the Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization Study (meSH): Multicenter Survey Study. JMIR Formative Research 2024;8:e48767 View
- Green N, Manwani D, Aygun B, Appiah‐Kubi A, Smith‐Whitley K, Castillo Y, Soriano L, Jia H, Smaldone A. Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease. Pediatric Blood & Cancer 2024;71(4) View